All In Biotech

Drug Trial Radar · NCT00355134

Efficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple Sclerosis

24-month Double-blind, Randomized, Multicenter, Placebo-controlled, Parallel-group Study Comparing the Efficacy and Safety of 0.5 mg and 1.25 mg Fingolimod (FTY720) Administered Orally Once Daily Versus Placebo in Patients With Relapsing-remitting Multiple Sclerosis With Optional Extension Phase

Last checked: Nov 20, 2026Latest source record: Aug 7, 2012 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 1,083 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,083

Actual

Start

Jun 2006

Primary completion

Jun 2011

Study completion Aug 2011

Sponsor

Lead sponsor
NovartisNovartis (NVS)
Sponsor type
Industry
First posted
Jul 21, 2006

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 55 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study assessed the safety, tolerability and efficacy of two doses of oral fingolimod compared to placebo on efficacy parameters in patients with relapsing-remitting multiple sclerosis (RRMS).

Conditions

  • Multiple Sclerosis

Interventions

  • FingolimodDrug

    Fingolimod capsules for oral administration

  • PlaceboDrug

    Matching placebo capsules for oral administration.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Aggregate Annualized Relapse Rate (ARR) Estimate up to Month 24Time frame: 24 months

Locations

112 sites in 8 countries. Site status is shown where the registry gives one.

  • University of Alabama Birmingham

    Birmingham, Alabama

  • North Central Neurology Associates, PC

    Cullman, Alabama

  • University of South Alabama - Dept of Neurology

    Mobile, Alabama

  • Barrow Neurology Clinic

    Phoenix, Arizona

  • Research and Education Institute of Alta Bates Summit Medical Center

    Berkeley, California

  • University of California - Irvine, Deptarment of Neurology

    Irvine, California

  • Cedars Sinai Medical Center

    Los Angeles, California

  • The Neurology Center

    Oceanside, California

  • Neuro-Therapeutics, Inc.

    Pasadena, California

  • UC Davis Medical Center

    Sacramento, California

  • Multiple Sclerosis Center at UCSF

    San Francisco, California

  • University of Colorado

    Denver, Colorado

  • Associated Neurologists, PC

    Danbury, Connecticut

  • Associated Neurologists of Southern CT, P.C.

    Fairfield, Connecticut

  • Yale University - Yale Multiple Sclerosis Center

    New Haven, Connecticut

  • Georgetown University Hospital - Dept of Neurology

    Washington D.C., District of Columbia

  • Sunrise Clinical Research, Inc.

    Hollywood, Florida

  • University of Florida Health Sciences Center/Shands Jacksonville

    Jacksonville, Florida

  • Neurology Associates, PA

    Maitland, Florida

  • University of Miami, Department of Neurology

    Miami, Florida

  • Neurological Associates

    Pompano Beach, Florida

  • Roskamp Institute, Clinical Trials Division

    Sarasota, Florida

  • Neurology Clinical Research, Inc

    Sunrise, Florida

  • AMO Corporation

    Tallahassee, Florida

  • Axiom Clinical Research of Florida

    Tampa, Florida

  • The MS Center of Vero Beach

    Vero Beach, Florida

  • MS Center of Atlanta

    Atlanta, Georgia

  • Medical College of Georgia

    Augusta, Georgia

  • Northwestern University Medical School - Dept of Neurology

    Chicago, Illinois

  • Rush University Medical Center Department of Neurological Sciences

    Chicago, Illinois

  • University of Chicago - Dept of Neurology

    Chicago, Illinois

  • Alexian Brothers Neurosciences Research

    Elk Grove Village, Illinois

  • South Suburban Neurology

    Flossmoor, Illinois

  • Neurologic Associates, Ltd.

    Palos Heights, Illinois

  • Fort Wayne Neurological Center

    Fort Wayne, Indiana

  • Indiana University Medical Center

    Indianapolis, Indiana

  • Ruan Neurology Clinical Research Center

    Des Moines, Iowa

  • University of Kansas Medical Center

    Kansas City, Kansas

  • Mid America Neuroscience Institute

    Lenexa, Kansas

  • Kentucky Research Associates

    Louisville, Kentucky

Showing 40 of 112 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.